Compare PLSE & RPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLSE | RPD |
|---|---|---|
| Founded | 2014 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2016 | 2015 |
| Metric | PLSE | RPD |
|---|---|---|
| Price | $14.09 | $15.75 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 21 |
| Target Price | $22.00 | ★ $24.00 |
| AVG Volume (30 Days) | 183.4K | ★ 1.2M |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.35 |
| Revenue | $86,000.00 | ★ $858,667,000.00 |
| Revenue This Year | N/A | $2.63 |
| Revenue Next Year | $1,002.94 | $1.65 |
| P/E Ratio | ★ N/A | $46.97 |
| Revenue Growth | N/A | ★ 3.08 |
| 52 Week Low | $12.56 | $13.21 |
| 52 Week High | $25.00 | $42.09 |
| Indicator | PLSE | RPD |
|---|---|---|
| Relative Strength Index (RSI) | 47.40 | 46.12 |
| Support Level | $13.12 | $15.73 |
| Resistance Level | $14.75 | $16.88 |
| Average True Range (ATR) | 0.61 | 0.52 |
| MACD | 0.22 | 0.14 |
| Stochastic Oscillator | 58.33 | 20.54 |
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.